Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions

Journal of Clinical Pathology

Volumn 51, Issue 10, 1998, Pages 737-740

  Clavel, Christine ^a,b   Masure, Marie ^a   Putaud, Isabelle ^a   Thomas, Kathleen ^a   Bory, Jean Paul ^a   Gabriel, René ^a   Quereux, Christian ^a   Birembaut, Philippe ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Hybrid capture

Indexed keywords

VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; HUMAN TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0031784623     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.10.737     Document Type: Article

References (23)

1. Bosch FX, Manos MM, Munoz N, et al and International Biological Study in Cervical Cancer Study Group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
2. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: relative risk association of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
3. Van den Brule AJC, Walboomers AJM, Du Maine M, et al. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991;48:404-8.
4. Zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
5. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
6. Gaarenstrom KN, Melkert P, Walboomers JMM, et al. Human papillomavirus DNA genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer 1994;4:73-8.
7. Cole HM. Human papillomavirus DNA testing in the management of cervical neoplasia. JAMA 1993;270:2975-81.
8. Cox JT, Lorincz AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
9. Richart RM, Wright TC. Controversies in the management of low grade cervical intraepithelial neoplasia. Cancer 1993; 71:1413-21.
10. Jacobs MV, Snidjers PJF, Van den Brule AJC, et al. A general primer GP5+/GP6+ mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35:791-5.
11. Lungu O, Sun XW, Wright TC, et al. A polymerase chain reaction-enzyme linked immunosorbent assay method detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet Gynecol 1995;85:337-42.
12. Clavel C, Rihet S, Masure M, et al. DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6 E7 primer mediated multiplex PCR. J Clin Pathol 1998;51:38-43.
13. Farthing A, Masterson P., Mason WP, et al. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol 1994;47:649-52.
14. Schiffman MA, Kiviat NB, Burk RD, et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 1995;33:545-50.
15. Sun XW, Ferenczy A, Johnson D, et al. Evaluation of the hybrid capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol 1995;173:1432-7.
16. Hatch KD, Scheider A, Addel-Nour MW. An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am J Obstet Gynecol 1995;172:1150-7.
17. Brown DR, Rawlings K, Handy V, et al. Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens. J Med Virol 1996;48: 210-4.
18. Clavel C, Bory JP, Rihet S, et al. Comparative analysis of the human papillomavirus detection by hybrid capture assay and routine cytologic screening to detect high grade cervical lesions. Int J Cancer 1998;75:525-8.
19. Lorincz AT. Hybrid capture method tor detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep 1996;7:1-5.
20. De Roda Husman AM, Walboomers JM, Van den Brule AJC, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
21. Nindl I, Zahm DM, Meijer CJLM, et al. Human papillomavirus detection in high-grade squamous intraepithelial lesions. Comparison of hybrid capture assay with a polymerase chain reaction system. Diagn Microbiol Infect Dis 1995;23:161-4.
22. Cuzick J, Terry G, Ho L, et al. Human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994;69: 167-71.
23. Ho GYF, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.